Central Surgical AssociationApplication of an individualized operative strategy for wedge resection of gastric gastrointestinal stromal tumors: Effectiveness for tumors in difficult locations
Section snippets
Patient selection
All patients undergoing resection of gastric GISTs from 2000–2014 at the Montreal General Hospital of the McGill University Health Centre were identified from a prospectively collected database. These were then cross-referenced against the operative booking database of all gastric resections performed during the study period. Pathology records of these patients were reviewed to identify all patients who had pathology-proven gastric resection for GIST. In total, 59 patients met inclusion
Results
From 2000–2014, a total of 59 patients were identified who had undergone operative resection for pathologically proven gastric GIST (median age, 65 [34–83] years; 26 [44%] male). The procedure was completed laparoscopically in 41 (71%) patients, open in 14 (24%) patients, and converted to open in 3 (5.1%) patients. Wedge resection was performed in 54 (92%) patients, and anatomic resection in 5 (8.5%) patients. The characteristics of study participants and operative approach are summarized in
Discussion
This study summarizes 14 years of experience at a single, tertiary care center regarding the operative techniques of gastric GIST resection across a wide range of tumor sizes and locations. Laparoscopic and nonanatomic resection were achieved in the vast majority of cases, in accordance with currently accepted preferred resection strategies.14 Nonanatomic resection was achieved for the majority of tumors (14/16) at the antrum and cardia. In conjunction with proper long-term follow-up and
References (27)
- et al.
Incidence of gastrointestinal stromal tumors is underestimated: results of a nation-wide study
Eur J Cancer
(2005) - et al.
Gastrointestinal stromal tumor
Lancet
(2013) Risk stratification of patients diagnosed with gastrointestinal stromal tumor
Hum Pathol
(2008)- et al.
Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localized, primary gastrointestinal stromal tumor (GIST): a retrospective analysis
Lancet Oncol
(2009) - et al.
Gastrointestinal stromal tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up
Ann Oncol
(2008) - et al.
Placebo-controlled randomized trial of adjuvant imatinib mesylate following the resection of localized, primary gastrointestinal stromal tumor (GIST)
Lancet
(2009) - et al.
Diagnosis of gastrointestinal stromal tumors: a consensus approach
Hum Pathol
(2002) - et al.
Gastrointestinal stromal tumors: origin and molecular oncology
Nat Rev Cancer
(2011) - et al.
World J Gastroenterol
(2006) - et al.
Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era—a population-based study in western Sweden
Cancer
(2005)
Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival
Ann Surg
NCCN Task Force Report: update on the management of patients with gastrointestinal stromal tumors
J Natl Compr Canc Netw
Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor (GIST): ACOSOG Z9000 (Alliance) intergroup phase 2 trial
Ann Surg
Cited by (0)
Carmen L. Mueller and Josef Braun contributed equally to this work.